desmopressin Search Results


90
TargetMol eh guinea pig model
Eh Guinea Pig Model, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/Desmopressin+acetate/pmc09035551-62-1-16
Average 90 stars, based on 1 article reviews
eh guinea pig model - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Tocris desmopressin
V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist <t>desmopressin</t> 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.
Desmopressin, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/Desmopressin/pmc06295453-81-0-10
Average 93 stars, based on 1 article reviews
desmopressin - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Selleck Chemicals ddavp
V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist <t>desmopressin</t> 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.
Ddavp, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/Desmopressin+Acetate/pm40227313-38-25-26
Average 93 stars, based on 1 article reviews
ddavp - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Biosynth Carbosynth fd21366
V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist <t>desmopressin</t> 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.
Fd21366, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/Desmopressin+acetate/pmc09059125-164-0-4
Average 92 stars, based on 1 article reviews
fd21366 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
TargetMol desmopressin acetate
V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist <t>desmopressin</t> 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.
Desmopressin Acetate, supplied by TargetMol, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/Desmopressin/pmc09035551-62-11-16
Average 92 stars, based on 1 article reviews
desmopressin acetate - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
CSL Behring desmopressin acetate
V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist <t>desmopressin</t> 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.
Desmopressin Acetate, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/desmopressin+acetate/pmc06513131-184-51-67
Average 90 stars, based on 1 article reviews
desmopressin acetate - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Gneuss Kunststofftechnik desmopressin
V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist <t>desmopressin</t> 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.
Desmopressin, supplied by Gneuss Kunststofftechnik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/desmopressin/pm37611608-155-18-8
Average 90 stars, based on 1 article reviews
desmopressin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Synpeptide Co Ltd desmopressin as tfa salt
V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist <t>desmopressin</t> 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.
Desmopressin As Tfa Salt, supplied by Synpeptide Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/desmopressin+as+tfa+salt++purity+++98+/pm36657829-74-0-10
Average 90 stars, based on 1 article reviews
desmopressin as tfa salt - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ferring Pharmaceuticals minirins (desmopressin)
V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist <t>desmopressin</t> 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.
Minirins (Desmopressin), supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/desmopressin+minirinr/pm15001983-44-7-9
Average 90 stars, based on 1 article reviews
minirins (desmopressin) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ferring Pharmaceuticals desmopressin nocdurna
Agents pending FDA approval: November 16, 2014 through December 12, 2014
Desmopressin Nocdurna, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/desmopressin+nocdurna/pmc04336018-48-2-3
Average 90 stars, based on 1 article reviews
desmopressin nocdurna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Ferring Pharmaceuticals desmopressin acetate minirin 4 μg/
Agents pending FDA approval: November 16, 2014 through December 12, 2014
Desmopressin Acetate Minirin 4 μg/, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/desmopressin/desmopressin+minirin/pm36479816-28-19-25
Average 90 stars, based on 1 article reviews
desmopressin acetate minirin 4 μg/ - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.

Journal: Frontiers in Neuroscience

Article Title: Dynamic Modulation of Mouse Locus Coeruleus Neurons by Vasopressin 1a and 1b Receptors

doi: 10.3389/fnins.2018.00919

Figure Lengend Snippet: V1b receptor modulation directly alters LC noradrenergic neuronal activity. (A) Post hoc microscopical confirmation of the molecular identity and location of recorded neurons. (A1) Shows immunoreactivity for biocytin which was originally contained within the intracellular solution used for recording the neuron in the whole-cell configuration. Note that immunoreactivity is located exclusively within the single neuron (arrow). (A2) Shows immunoreactivity for TH within the same filed of view as (A1) , confirming that the recording was from the LC, with the arrow highlighting the recorded cell. (A3) Is an overlay and magnified view the cell in (A1,A2) confirming that the recorded cell is TH immunopositive and thus a noradrenergic LC neuron. (B1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (B2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin (DES). (B3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (C1) representative traces of the spontaneous firing pattern of an LC neurons before and after the application of the V1b receptor agonist desmopressin 200 μM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (C2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of desmopressin. (C3) Quantification of the after hyperpolarization time constant (msec) of LC neurons before and after the application of desmopressin. (D1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b receptor antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant increase in the frequency of spontaneous action potentials. (D2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (D3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. (E1) Representative traces of the spontaneous firing pattern of an LC neuron before and after the application of the V1b antagonist TASP 0390325, 20 nM, from a cohort of neurons that responded with a significant decrease in the frequency of spontaneous action potentials. (E2) Quantification of the spontaneous firing rates (Hz) of LC neurons before and after the application of TASP 039325. (E3) Quantification of the afterhyperpolarization time constant (msec) of LC neurons before and after the application of TASP 039325. For graphs in (B–E) , the dots represent the values for individual cells, the long red bars represents the mean for all cells within that group, and the short red bars represent the SEM. ∗ p < 0.05, paired Student’s t -test. Scale bars (A1,A2) 50 μm; (A3) 20 μm; (B1,C1,D1,E1) horizontal bar 1 s, vertical bar 10 mV.

Article Snippet: Desmopressin, [d(CH2)51, Tyr(Me)2, Arg8]-Vasopressin and TASP 0390325 were obtained from Tocris, United Kingdom, and dissolved in ECS.

Techniques: Activity Assay

Agents pending FDA approval: November 16, 2014 through December 12, 2014

Journal: Hospital Pharmacy

Article Title: Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals

doi: 10.1310/hpj5002-154

Figure Lengend Snippet: Agents pending FDA approval: November 16, 2014 through December 12, 2014

Article Snippet: Desmopressin , Nocdurna (Ferring Pharmaceuticals) , Orally disintegrating sublingual tablets for the treatment of nocturia due to nocturnal polyuria in adults who awaken 2 or more times each night to void (meeting date: January 12, 2015).

Techniques: Virus, Infection, Transplantation Assay